BX Swiss TOP 30 CHF
1.355,63
PKT
-0,75
PKT
-0,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.01.26 | Nestlé Hold | Jefferies & Company Inc. | |
| 07.01.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 06.01.26 | ABB (Asea Brown Boveri) Underweight | Barclays Capital | |
| 06.01.26 | Givaudan Equal-weight | Morgan Stanley | |
| 05.01.26 | Swiss Re Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.01.26 | Swiss Re Underperform | RBC Capital Markets | |
| 05.01.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 05.01.26 | Novartis Overweight | JP Morgan Chase & Co. | |
| 05.01.26 | Richemont Buy | UBS AG | |
| 30.12.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 30.12.25 | Nestlé Market-Perform | Bernstein Research | |
| 23.12.25 | Novartis Overweight | JP Morgan Chase & Co. | |
| 23.12.25 | Roche Neutral | JP Morgan Chase & Co. | |
| 18.12.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 18.12.25 | Nestlé Market-Perform | Bernstein Research | |
| 18.12.25 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.12.25 | Nestlé Market-Perform | Bernstein Research | |
| 17.12.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 17.12.25 | Zurich Insurance Sell | UBS AG | |
| 17.12.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 17.12.25 | Swiss Re Neutral | UBS AG | |
| 16.12.25 | UBS Kaufen | DZ BANK | |
| 16.12.25 | Novartis Buy | Deutsche Bank AG | |
| 15.12.25 | Nestlé Neutral | UBS AG | |
| 15.12.25 | UBS Buy | Deutsche Bank AG | |
| 15.12.25 | Roche Hold | Deutsche Bank AG | |
| 15.12.25 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.12.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 12.12.25 | Roche Hold | Deutsche Bank AG | |
| 12.12.25 | Givaudan Buy | Deutsche Bank AG | |
| 12.12.25 | Givaudan Neutral | UBS AG | |
| 12.12.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 11.12.25 | Givaudan Buy | Jefferies & Company Inc. | |
| 11.12.25 | Givaudan Overweight | Barclays Capital | |
| 11.12.25 | Richemont Overweight | Barclays Capital | |
| 11.12.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 11.12.25 | Roche Buy | UBS AG | |
| 11.12.25 | Roche Neutral | JP Morgan Chase & Co. | |
| 11.12.25 | Roche Underperform | Jefferies & Company Inc. | |
| 10.12.25 | Swiss Re Neutral | Goldman Sachs Group Inc. |